Key Finding
Acupuncture at highly sensitive (lowest pain threshold) force-sensitive acupoints produced significantly better outcomes for IBS-D symptom severity and quality of life compared to treatment at low-sensitivity points.
Researchers in China studied whether acupuncture could help people with diarrhea-predominant irritable bowel syndrome (IBS-D), a condition causing frequent diarrhea, abdominal pain, and reduced quality of life. The study involved 108 patients divided into three groups. Two groups received acupuncture treatments three times weekly for six weeks, while a third group received no treatment during the study period. The innovative approach involved identifying "force-sensitive" acupuncture points—areas on the body that were either highly sensitive or less sensitive to pressure. One group received needling at their most sensitive points (lowest pain threshold), while another group was treated at their least sensitive points (highest pain threshold). Both acupuncture groups showed significant improvements in symptom severity, quality of life, and stool consistency compared to the waiting group. However, patients who received acupuncture at their most sensitive points experienced greater relief than those treated at less sensitive points. These improvements lasted through the follow-up period after treatment ended. No serious side effects occurred in any group. The findings suggest that acupuncture can effectively treat IBS-D symptoms, and that personalizing treatment by targeting the body's most sensitive points may produce better outcomes. This approach offers a safe, non-medication option for managing this challenging digestive condition. If you're considering acupuncture for IBS-D, seek a licensed acupuncturist trained in traditional Chinese medicine diagnostics.
This randomized controlled trial evaluated acupuncture at force-sensitive acupoints for diarrhea-predominant IBS in 108 patients across three groups: high-sensitivity acupoint treatment (n=34), low-sensitivity acupoint treatment (n=35), and waitlist control (n=34). Sensitivity was determined by pain threshold measurement. Both treatment groups received acupuncture three times weekly for six weeks. Primary outcomes included IBS Severity Scale (IBS-SSS), IBS Quality of Life (IBS-QOL), and Bristol Stool Form Scale (BSFS). Both acupuncture groups demonstrated statistically significant improvements in all measures compared to controls (P<0.05), with benefits maintained at follow-up. Critically, the high-sensitivity group showed superior outcomes to the low-sensitivity group in IBS-SSS scores at weeks 4 and 6 and follow-up (P<0.05), and in IBS-QOL scores post-treatment and follow-up (P<0.05). No adverse events were reported. Clinical implication: Individualized acupoint selection based on pressure sensitivity assessment may optimize treatment outcomes for IBS-D, with highly sensitive points producing greater therapeutic effects.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.